**Core Concept**
Chediak-Higashi syndrome is a rare genetic disorder characterized by oculocutaneous albinism, immunodeficiency, and bleeding tendency. The defect lies in the lysosomal trafficking regulator protein (LYST), which plays a crucial role in the biogenesis and function of lysosomes.

**Why the Correct Answer is Right**
The correct answer is related to the LYST gene, which encodes a protein involved in the regulation of lysosomal fusion and fission. Mutations in the LYST gene lead to the formation of abnormally large lysosomes, resulting in the characteristic cellular and clinical features of Chediak-Higashi syndrome. This defect impairs the function of natural killer cells and other immune cells, leading to recurrent infections and autoimmune manifestations.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not relate to the Chediak-Higashi syndrome. The correct answer is related to the LYST gene, which is specific to this disorder.

**Option B:** This option is incorrect because it refers to another genetic disorder, Hermansky-Pudlak syndrome, which involves a different set of genes and cellular defects.

**Option C:** This option is incorrect because it is a general term that can refer to various genetic disorders, but it is not specific to Chediak-Higashi syndrome.

**Clinical Pearl / High-Yield Fact**
Chediak-Higashi syndrome is characterized by a triad of oculocutaneous albinism, immunodeficiency, and bleeding tendency. It is essential to recognize this rare disorder to provide accurate diagnosis and management.

**Correct Answer:** D. LYST gene defect